Poland· PL-100111506
Glycophos
A electrolyte solutions product containing natrii glycerophosphas, registered in Poland by Fresenius Kabi AB. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Natrii glycerophosphas is registered in 2 of 19 countries.
Countries holding a registration under ATC B05XA (electrolyte solutions), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Natrii glycerophosphas · ATC B05XA
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Natrii glycerophosphas
- Manufacturer
- Fresenius Kabi AB
- Country
- Poland (PL)
- ATC code
- B05XA
- ATC class
- Electrolyte solutions
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990971916
- gtin05909991410582
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natrii glycerophosphas in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayGlycophosFresenius Kabi
- BelgiumGlycophos 20 mlFresenius Kabi
- United KingdomGlycophos 4.32g/20ml concentrate for solution for infusion vialsFresenius Kabi Ltd
- FinlandGlycophosFresenius Kabi AB
- CzechiaSODIUM GLYCEROPHOSPHATE FRESENIUSFresenius Kabi s.r.o., Praha
- FranceGLYCEROPHOSPHATE DE SODIUM KABI 216 mg/mL (1 mmol/mL), solution à diluer pour perfusionFRESENIUS KABI FRANCE
- GermanyNatriumglycerophosphat-Ampulle FreseniusFresenius Kabi Deutschland Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Glycophos
- Belgium · Glycophos
- Cyprus · Glycophos
- Czechia · Sodium Glycerophosphate Fresenius
- Germany · Natriumglycerophosphat-Ampulle Fresenius
- Denmark · Glycophos
- Spain · Glycophos
- Finland · Glycophos
- France · Glycerophosphate De Sodium
- Greece · Glycophos
- Hungary · Nátrium-Glicerin-Foszfát Fresenius
- Italy · Glycophos
- Lithuania · Glycophos
- Latvia · Glycophos
- Netherlands · Glycophos
- Portugal · Glycophos
- Romania · Glycophos
- Sweden · Glycophos
- Slovakia · Sodium Glycerophosphate Fresenius
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/07e3d505-0a42-403b-af8d-6c8d49930e52 GET /v1/drugs/07e3d505-0a42-403b-af8d-6c8d49930e52?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "216 mg/ml",
"packaging": "05909990971916 ¦ Lz ¦ 19939\n10 fiol. 20 ml\n05909991410582 ¦ Lz ¦ 133530\n20 amp. 20 ml",
"substance": "Natrii glycerophosphas 216 mg (306,1 mg sodu glicerofosforanu uwodnionego)",
"common_name": "Natrii glycerophosphas",
"pl_product_id": "100111506",
"pozwolenie_nr": "09719",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about natrii glycerophosphas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.